Better medicines for children: EU Commission initiative to get best and safest treatments for children Part 1

We have mixed up all the articles (a, an, the) in the text below, try and find the correct place for each one..

Better medicines for children: EU Commission initiative to get best and safest treatments for children Part 1 (Teacher: Michael)

Towards end of year EU Commission may finalise proposal to ensure that medicines are adapted to specific needs of children. Currently, Commission is analysing reactions its ideas made public in consultation paper at end of last February.

More than half medicines used for children are not tested for their paediatric suitability.

The EU document lists objectives that any new rules aiming to remedy shortage of child-specific medicines should meet, and suggests ways to attain them. Comments were invited from doctors, parents, pharmaceutical manufacturers, regulators or anyone having interest in matter.

The response was "generally positive and supportive," Dr Julia Dunne told me on morrow of her assuming her new post in Orphan and Paediatric Medicinal Products section of DG Enterprise on July 1.

The EU paper was presented by Erkki Liikanen, EU Commissioner for Enterprise and Information Society, and David Byrne, EU Commissioner for Health and Consumer Protection. "To get best and safest treatments for children across Europe," said Liikanen, "society must strike right balance between incentives and regulatory obligations. We need to move forward on this important matter to ensure that both existing and new medicines are adapted to paediatric needs in most resource-efficient manner for society as whole.

Read the article